Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene

Blood

Volumn 97, Issue 1, 2001, Pages 122-129

  Garin, Marina I ^b   Garrett, Elaine ^b   Tiberghien, Pierre ^b   Apperley, Jane F ^a   Chalmers, David ^b   Melo, Junia V ^b   Ferrand, Christophe ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GANCICLOVIR; THYMIDINE KINASE; VIRUS VECTOR;

ARTICLE; CLINICAL ARTICLE; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENE THERAPY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; PRIORITY JOURNAL; RETROVIRUS; STEM CELL TRANSPLANTATION;

EID: 0035174929     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.1.122     Document Type: Article

References (38)

1. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings
2. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies
3. Graft-versus-host-disease: Immunology, pathophysiology and treatment
4. Improved survival after bone marrow transplantation for early leukemia using busulfan-cyclophosphamide and individualized prophylaxis against graft-versus-host disease: A long-term follow-up
5. New strategies for preventing graft-versus-host disease
6. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients
7. "Suicide" gene for the control of graft-versus-host disease
8. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
9. Herpes simplex virus type 1 and human DNA polymerase interactions with 2′-deoxyguanosine 5′-triphosphate analogues: Kinetics of incorporation into DNA and induction of inhibition
10. Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor antitumor immunity after allogeneic bone marrow transplantation
11. Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: A phase I-II study
12. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
13. Adoptive immunotherapy for leukemia: Donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction
14. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: Clinical follow-up and improved new vectors
15. Gene transfer applied to the modulation of alloreactivity
16. Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration
17. An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo
18. A closed culture system for the ex vivo transduction and expansion of human T lymphocytes
19. Development of a competitive PCR method for in vitro and in vivo quantification of herpes simplex virus thymidine kinase and neomycin resistance-expressing cells used in a clinical trial
20. P190BCR-ABL chronic myeloid leukaemia: The missing link with chronic myelomonocytic leukaemia?
21. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells
22. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors
23. Gene therapy for cancer
24. Drug sensitivity ("suicide") genes for selective cancer chemotherapy
25. Mechanism of "bystander effect" killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment
26. A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect
27. The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified
28. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: An approach for specific in vivo donor T-cell depletion after bone marrow transplantation?
29. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene
30. Thymidine kinase-mediated killing of rat brain tumors
31. Limitations of retrovirus-mediated HSV-tk gene transfer to pulmonary adenocarcinoma cells in vitro and in vivo
32. Retroviral transfer of herpes simplex virus-thymidine kinase and beta-galactosidase genes into U937 cells with bicistronic vector
33. Inhibition by ganciclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information
34. Costimulation of transduced T lymphocytes via T cell receptor-CD3 complex and CD28 leads to increased transcription of integrated retrovirus
35. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene
36. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice
37. Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells
38. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft